scispace - formally typeset
S

Sang Wook Son

Researcher at Korea University

Publications -  137
Citations -  2528

Sang Wook Son is an academic researcher from Korea University. The author has contributed to research in topics: Atopic dermatitis & HaCaT. The author has an hindex of 25, co-authored 130 publications receiving 2166 citations. Previous affiliations of Sang Wook Son include Hanyang University & Konkuk University.

Papers
More filters
Journal ArticleDOI

Highly Sensitive Immunoassay of Lung Cancer Marker Carcinoembryonic Antigen Using Surface-Enhanced Raman Scattering of Hollow Gold Nanospheres

TL;DR: A quick and reproducible surface-enhanced Raman scattering (SERS)-based immunoassay technique, using hollow gold nanospheres (HGNs) and magnetic beads, has been developed, which overcomes the problem of slow immunoreaction caused by the diffusion-limited kinetics on a solid substrate.
Journal ArticleDOI

Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres.

TL;DR: The results demonstrate the potential feasibility of HGNs as highly sensitive and homogeneous sensing probes for biological imaging of cancer markers in live cells.
Journal ArticleDOI

SERS imaging of HER2-overexpressed MCF7 cells using antibody-conjugated gold nanorods

TL;DR: The experimental results demonstrate the potential feasibility of antibody-conjugated GNRs for the highly sensitive targeting and imaging of biomarkers expressed on the surface membrane of cancer cells.
Journal ArticleDOI

Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity

TL;DR: In this article, two different sizes (20 nm and 100 nm) and different charges (negatively charged [NC] and weakly negatively charged [WNC]) of silica NPs were used.
Journal ArticleDOI

Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity

TL;DR: It is demonstrated that the use of a biodegradable hydrogel system for the co-delivery of an immunoadjuvant and an anti-cancer drug for successful chemo-immunotherapy results in synergistic anti-tumor effects, which occur via the induction of a tumor antigen-specific CD8+ T cell-mediated anti-Tumor immunity.